PROGNOSTIC SIGNIFICANCE RBC TRANSFUSIONS' VOLUME INFUSED DURING THE FIRST INDUCTION CHEMOTHERAPY TO PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA (AML)

被引：0
作者：
Davaasambuu, B. [1 ]
Gritsaev, S. [1 ]
机构：
[1] Russian Inst Hematol & Transfusiol, St Petersburg, Russia
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1304
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [41] Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia (AML)
    Arellano, M. L.
    Winton, E.
    Pan, L.
    Souza, L.
    Sunay, S.
    Lima, L.
    McLemore, M.
    Heffner, L. T.
    Langston, A.
    Khoury, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Lee, J. -H.
    Joo, Y. -D.
    Kim, H.
    Bae, S. H.
    Kim, M. K.
    Zang, D. Y.
    Lee, J. -L.
    Lee, G. W.
    Lee, J. -H.
    Park, J. -H.
    Kim, D. -Y.
    Lee, W. -S.
    Ryoo, H. M.
    Hyun, M. S.
    Kim, H. J.
    Min, Y. J.
    Lee, K. -H.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [43] Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia:: A study from the Acute Leukemia French Association (ALFA).
    Preudhomme, C
    Sagot, C
    Boissel, N
    Cayuela, JM
    Tigaud, I
    de Botton, S
    Thomas, X
    Raffoux, E
    Lamandin, C
    Castaigne, S
    Fenaux, P
    Dombret, H
    BLOOD, 2002, 100 (11) : 746A - 746A
  • [44] Prognostic significance of programmed death ligand 1 expression in adult patients with de-novo acute myeloid leukemia
    Mostafa, Nevine N.
    Abdelmohsen, Emad A.
    El-Ghammaz, Amro M. S.
    Saeed, Alia M.
    Hamza, Mohammed T.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (04) : 158 - 165
  • [45] Cytomegalovirus DNAemia in patients with de novo acute myeloid leukemia undergoing cytotoxic chemotherapy
    Tormo, Mar
    Gimenez, Estela
    Calabuig, Marisa
    Talaya, Alberto
    Navarro, Blanca
    Amat, Paula
    Martin, Ivan
    Albert, Eliseo
    Solano, Carlos
    Navarro, David
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 3081 - 3083
  • [46] VARIATIONS OF SERUM ACSDKP CONCENTRATIONS DURING INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML)
    LIOZON, E
    VOLKOV, L
    COMTE, L
    TRIMOREAU, F
    PRADELLES, P
    BORDESSOULE, D
    FRINDEL, E
    PRALORAN, V
    BLOOD, 1994, 84 (10) : A305 - A305
  • [47] Prognostic value of serum progranulin in de novo adult acute myeloid leukemia patients
    Azazzi, Mohamed O.
    El-Ghammaz, Amro M. S.
    Mohamed, Haydi S.
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (01) : 25 - 31
  • [48] Prognostic Value of Serum Progranulin in De Novo Adult Acute Myeloid Leukemia Patients
    Azzazi, Mohamed
    El Ghammaz, Amro
    Mohamed, Haydi Sayed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S225 - S225
  • [49] Daunorubicin versus mitoxantrone for induction therapy of patients of de novo acute myeloid leukemia
    Varadpande, L.
    Rajappa, S.
    Naidu, N.
    Digumarti, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] Prognostic Significance of Karyotype in Octogenarian Patients (Pts) with Acute Myeloid Leukemia (AML)-An International Study
    Wetzler, Meir
    Kohlschmidt, Jessica
    Mrozek, Krzysztof
    Dombret, Herve
    Doehner, Hartmut
    Pilorge, Sylvain
    Krug, Utz
    Larson, Richard A.
    Marcucci, Guido
    Hiddemann, Wolfgang
    Buchner, Thomas
    Bloomfield, Clara D.
    BLOOD, 2011, 118 (21) : 1080 - 1081
12345